Cancer Proteomics

Date: Tuesday, 16 October 2012 - Wednesday, 17 October 2012
Location: Madrid, Spain

Keynote Speakers

Ruedi Aebersold
Professor, Institute for Systems Biology

Sam Hanash
Director, McCombs Institute for Cancer Detection and Treatment, University of Texas MD Anderson Cancer Center

William Gallaghr
Chief Scientific Officer/Professor, OncoMark Limited/University College Dublin

Overview

Welcome to the Cancer Proteomics track of the Systems Biology Europe conference and exhibition. This year's event will be held in Madrid, the capital and largest city of Spain.

The focus of this conference track will be on current advances in proteomic technologies applied to cancer research, both in diagnosis, prognosis and therapeutic development. Presentations will cover the use of mass-spectrometry and array-based technologies for the discovery, identification and validation of biomarkers in a range of cancers.

Other conference tracks at this event include Informatics, Exosomes/Markers in Biological Fluids and Metabolic Profiling & Lipidomics. Registered delegates will have access to all four meetings ensuring a very cost-effective trip.

In addition the event will also host two cutting edge business courses which can be viewed here.

Agenda Topics

Array-Based Technologies
Cancer Biomarker Development
Informatics Approaches and Computational Biology
Proteomics for Mechanistic Insight into Cancer
Proteomics in Development of Anti-Cancer Therapeutics
Signalling and Systems Biology

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

, ,
Jose Alvarez, Staff Scientist, Center for Biological Investigation
Emmanuel Barillot, Bioinformatics and IT Director, Institut Curie
Carl Borrebaeck, Professor and Deputy Vice Chancellor, Lund University
Lynn Cawkwell, Senior Lecturer, University of Hull
Connie Jimenez, Head, VU University Medical Center
Bernhard Kuster, Head, Technical University of Munich
Metodi Metodiev, Biological Safety Officer, University of Essex
Stephen Pennington, Professor, University College Dublin
Fredrik Ponten, Professor, Uppsala University
Peter Selby, Professor of Cancer Medicine, Leeds Institute of Molecular Medicine
Arzu Umar, Group Leader, Erasmus Medical Center Rotterdam/Josephine Nefkens Institute
Josep Villanueva, Group Leader, Vall d'Hebron Institute of Oncology
Andreas Weinhaeusel, Senior Scientist, Austrian Institute of Technology GmbH
Anthony Whetton, Professor, Manchester University
Sara Zanivan, Group Leader, Beatson Institute for Cancer Research